()-()
()-()

Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer

Last updated on - Apr 4, 2019

About this Gallery

Global pharmaceutical company Emcure Pharmaceuticals launched the world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) ... Read More

01 / 4
Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer
Sainath Iyer, Dr Adwait Gore and Dr Mukund Gurjar pose together during the launch of Eribulin held at St Regis in Mumbai. (BCCL/Prashant Jadhav)
See more of : Sainath Iyer, Dr Mukund Gurjar, Dr Adwait Gore
02 / 4
Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer
Dr Adwait Gore speaks while Sainath Iyer and Dr Mukund Gurjar look on during the launch of Eribulin held at St Regis in Mumbai. (BCCL/Prashant Jadhav)
See more of : Sainath Iyer, Dr Mukund Gurjar, Dr Adwait Gore
03 / 4
Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer
Sainath Iyer, Dr Adwait Gore and Dr Mukund Gurjar pose for the camera during the launch of Eribulin held at St Regis in Mumbai. (BCCL/Prashant Jadhav)
See more of : Sainath Iyer, Dr Mukund Gurjar, Dr Adwait Gore
04 / 4
Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer
Dr Adwait Gore and Dr Mukund Gurjar during the launch of Eribulin held at St Regis in Mumbai. (BCCL/Prashant Jadhav)
See more of : Dr Mukund Gurjar, Dr Adwait Gore
Never miss a trending photo
Like us on Facebook